Venous thromboembolic disease in autogenous breast reconstruction

Annals of Plastic Surgery

Volumn 63, Issue 1, 2009, Pages 34-38

  Pannucci, Christopher J ^a,b   Chang, Edwin Y ^a   Wilkins, Edwin G ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Autogenous tissue reconstruction; Breast cancer; Deep venous thrombosis; Pulmonary embolism; Venous thromboembolic disease

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST RECONSTRUCTION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL LITERATURE; MEDICAL PRACTICE; PRIORITY JOURNAL; VENOUS THROMBOEMBOLISM;

FEMALE; HUMANS; MAMMAPLASTY; MIDDLE AGED; VENOUS THROMBOEMBOLISM;

EID: 67651235923     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/SAP.0b013e318188bedf     Document Type: Article

References (49)

1. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126:338S- 400S.
2. Chew HK, Wun T, Harvey DJ, et al. Incidence of venous thromboembolism and the impact on survival in breast cancer patients. J Clin Oncol. 2007;25: 70-76. (Pubitemid 350003053)
3. Spear SL, Ducic I, Low M, et al. The effect of radiation on pedicled TRAM flap breast reconstruction: outcomes and implications. Plast Reconstr Surg. 2005;115:84-95. (Pubitemid 40187801)
4. Spear SL, Ducic I, Cuoco F, et al. Effect of obesity on flap and donor-site complications in pedicled TRAM flap breast reconstruction. Plast Reconstr Surg. 2007;119:788-795. (Pubitemid 46302829)
5. Spear SL, Ducic I, Cuoco F, et al. The effect of smoking on flap and donor-site complications in pedicled TRAM breast reconstruction. Plast Reconstr Surg. 2005;116:1873-1880.
6. Mehrara BJ, Santoro TD, Arcilla E, et al. Complications after microvascular breast reconstruction: experience with 1195 flaps. Plast Reconstr Surg. 2006;118:1100 -1109; discussion 1110-1111. (Pubitemid 44511401)
7. Olsson EH, Tukiainen E. Three-year evaluation of late breast reconstruction with a free transverse rectus abdominis musculocutaneous flap in a county hospital in Sweden: a retrospective study. Scand J Plast Reconstr Surg Hand Surg. 2005;39:33-38. (Pubitemid 40314642)
8. Wang HT, Hartzell T, Olbrich KC, et al. Delay of transverse rectus abdominis myocutaneous flap reconstruction improves flap reliability in the obese patient. Plast Reconstr Surg. 2005;116:613- 618; discussion 619-620. (Pubitemid 41077221)
9. Gabbay JS, Eby JB, Kulber DA. The midabdominal TRAM flap for breast reconstruction in morbidly obese patients. Plast Reconstr Surg. 2005;115: 764-770. (Pubitemid 40316418)
10. Hamdi M, Blondeel P, Van Landuyt K, et al. Bilateral autogenous breast reconstruction using perforator free flaps: a single center's experience. Plast Reconstr Surg. 2004;114:83- 89; discussion 90-92. (Pubitemid 39195630)
11. Guerra AB, Soueid N, Metzinger SE, et al. Simultaneous bilateral breast reconstruction with superior gluteal artery perforator (SGAP) flaps. Ann Plast Surg. 2004;53:305-310. (Pubitemid 39281893)
12. Arnez ZM, Bajec J, Bardsley AF, et al. Experience with 50 free TRAM flap breast reconstructions. Plast Reconstr Surg. 1991;87:470-478; discussion 479-482.
13. Hartrampf CR. Breast reconstruction with a transverse abdominal island flap. Persp Plast Surg. 1987;1:123-135.
14. Elliott CG, Goldhaber SZ, Jensen RL. Delays in diagnosis of deep vein thrombosis and pulmonary embolism. Chest. 2005;128:3372-3376. (Pubitemid 41698665)
15. Elting LS, Escalante CP, Cooksley C, et al. Outcomes and cost of deep venous thrombosis among patients with cancer. Arch Intern Med. 2004;164:1653-1661. (Pubitemid 39037944)
16. Lyman GH, Khorana AA, Falanga A, et al. American society of clinical oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol. 2007;25:5490-5505. (Pubitemid 350232226)
17. McDevitt NB. Deep vein thrombosis prophylaxis. American society of plastic and reconstructive surgeons. Plast Reconstr Surg. 1999;104:1923-1928.
18. Davison SP, Venturi ML, Attinger CE, et al. Prevention of venous thromboembolism in the plastic surgery patient. Plast Reconstr Surg. 2004;114:43E-51E.
19. Young VL, Watson ME. Continuing medical education article-patient safety: the need for venous thromboembolism (VTE) prophylaxis in plastic surgery. Aesth Surg J. 2006;26:157-175.
20. Agnelli G, Bolis G, Capussotti L, et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg. 2006;243:89-95. (Pubitemid 43054059)
21. Gatini D. Current approaches and controversial issues in the diagnosis of deep vein thrombosis via duplex Doppler ultrasound. J Clin Ultrasound. 2006;34:289-297.
22. Gibbs H, Hetherington R, Gibb S, et al. A negative duplex ultrasound scan alone excludes deep venous thrombosis in clinical practice. J Thromb Haemo. 2004;3(suppl 1):abstract P1037.
23. Schoepf UJ. Diagnosing pulmonary embolism: time to rewrite the textbooks. Int J Cardiovasc Imaging. 2005;21:155-163 (Pubitemid 41149238)
24. Winer-Muram HT, Rydberg J, Johnson MS, et al. Suspected acute pulmonary embolism: evaluation with multi-detector row CT versus digital subtraction pulmonary arteriography. Radiology. 2004;233:806-815.
25. Patiar S, Kirwan CC, McDowell G, et al. Prevention of venous thromboembolism in surgical patients with breast cancer. Br J Surg. 2007;94:412-420. (Pubitemid 46624718)
26. Levitan N, Dowlati A, Remick SC, et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore). 1999;78:285-291. (Pubitemid 29439263)
27. Rohrich RJ, Rios JL. Venous thromboembolism in cosmetic plastic surgery: maximizing patient safety. Plast Reconstr Surg. 2003;112:871-872.
28. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. ENOXACAN study group. Br J Surg. 1997;84:1099-1103.
29. Bergqvist D, Agnelli G, Cohen AT, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002;346:975-980. (Pubitemid 34983247)
30. Rasmussen MS. Preventing thromboembolic complications in cancer patients after surgery: a role for prolonged thromboprophylaxis. Cancer Treat Rev. 2002;28:141-144.
31. Rasmussen MS, Jorgensen LN, Wille-Jorgensen P, et al. Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study. J Thromb Haemost. 2006;4:2384-2390. (Pubitemid 44575433)
32. Leonardi MJ, McGory ML, Ko CY. The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: a systematic review of 33 randomized controlled trials. Arch Surg. 2006;141:790 -797; discussion 797-799.
33. Stratton MA, Anderson FA, Bussey HI, et al. Prevention of venous thromboembolism: adherence to the 1995 American college of chest physicians consensus guidelines for surgical patients. Arch Intern Med. 2000;160:334-340.
34. Kakkar AK, Levine M, Pinedo HM, et al. Venous thrombosis in cancer patients: insights from the FRONTLINE survey. Oncologist. 2003;8:381-388. (Pubitemid 36929723)
35. Kirwan CC, McCollum CN, Bundred NJ, et al. Current UK practice of thromboprophylaxis for breast surgery. Br J Surg. 2006;93:1224-1225. (Pubitemid 44547020)
36. Andtbacka RH, Babiera G, Singletary SE, et al. Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways. Ann Surg. 2006;243:96-101. (Pubitemid 43054060)
37. Wedgwood KR, Benson EA. Non-tumour morbidity and mortality after modified radical mastectomy. Ann R Coll Surg Engl. 1992;74:314-317.
38. Friis E, Horby J, Sorensen LT, et al. Thromboembolic prophylaxis as a risk factor for postoperative complications after breast cancer surgery. World J Surg. 2004;28:540-543. (Pubitemid 38802787)
39. von Tempelhoff GF, Harenberg J, Niemann F, et al. Effect of low molecular weight heparin (certoparin) versus unfractionated heparin on cancer survival following breast and pelvic cancer surgery: a prospective randomized doubleblind trial. Int J Oncol. 2000;16:815-824.
40. Clahsen PC, van de Velde CJ, Julien JP, et al. Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European organization for research and treatment of cancer breast cancer cooperative group study. J Clin Oncol. 1994;12:1266-1271.
41. Saphner T, Tormey DC, Gray R. Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol. 1991;9:286-294.
42. Fisher B, Costantino J, Redmond C, et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med. 1989;320:479-484. (Pubitemid 19062522)
43. Ageno W, Agnelli G, Imberti D, et al. Factors associated with the timing of diagnosis of venous thromboembolism: results from the MASTER registry. Thromb Res 2008;121:751-756.
44. Heit JA, Silverstein MD, Mohr DN, et al. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med. 1999;159:445-453. (Pubitemid 29108909)
45. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT study. Arch Intern Med. 1991;151:933-938.
46. Douketis JD, Kearon C, Bates S, et al. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA. 1998;279:458-462. (Pubitemid 28082257)
47. McLachlin J, Richards T, Paterson JC. An evaluation of clinical signs in the diagnosis of venous thrombosis. Arch Surg. 1962;85:738-744.
48. Goldhaber SZ, Hennekens CH, Evans DA, et al. Factors associated with correct antemortem diagnosis of major pulmonary embolism. Am J Med. 1982;73:822-826.
49. Haeger K. Problems of acute deep venous thromosis. II. Mobilization and discharge of the patient. Angiology. 1969;20:280-286.